Note 11 – Subsequent Events

In July 2025, the Company issued 150 shares of Series A-1 Preferred Stock in exchange for $150,000. The July issuance is convertible into 37,500 – 120,000 shares of common stock. Series A-1 shares are convertible into common stock, subject to shareholder approval. Investors of A-1 Shares also received 37,500 1-year A Warrants exercisable into common stock at 80% of 5-day VWAP, and 37,500 5-year B Warrants exercisable into common stock at $4.00. All outstanding A-1 shares (800) are convertible into 200,000 – 640,000 shares of common stock, subject to shareholder approval.

In August 2025, the Company entered into a 12% promissory note in the amount of $183,200. This loan has a maturity of May 2026 with the 1^st payment in January 2026.

In August 2025, the Company entered into a 22% promissory note in the amount of $58,000. This loan has a maturity of May 2026 with the 1^st payment in January 2026.